CSIMarket
 


Biotech Acquisition Company  (BIOT)
Other Ticker:  
 
    Sector  Financial    Industry Blank Checks
   Industry Blank Checks
   Sector  Financial

Cumulative Biotech Acquisition's Working Capital Ratio for Trailing Twelve Months Period

BIOT's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

BIOT Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 880.98 % 902.4 % - - -
Y / Y Current Assets Growth -85.87 % -88.61 % - - -
Working Capital Ratio for Trailing Twelve Months Period 0.09 0.23 0.79 2.24 2.83
Total Ranking # 4713 # 5417 # 5035 # 2885 #
Seq. Current Liabilities Growth 5.91 % 49.56 % 607.71 % -12.49 % 8.23 %
Seq. Current Assets Growth -34.48 % -53 % 3.29 % -55.58 % -47.2 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2022
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $4 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.09 below Biotech Acquisition Company average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Blank Checks industry 395 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Biotech Acquisition. While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about BIOT
Working Capital Ratio BIOT in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 396
Sector # 531
S&P 500 # 4755


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.94 0.76 0.09
(Dec 31 2021)   (Sep 30 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Blank Checks Industry Working Capital Ratio for Trailing Twelve Months Period
Avalon Acquisition Inc   0.25 
Aries I Acquisition Corporation  0.25 
Fintech Acquisition Corp Vi  0.25 
Hunt Companies Acquisition Corp. I  0.24 
Burgundy Technology Acquisition Corp  0.24 
Insu Acquisition Corp Iii  0.24 
Ibere Pharmaceuticals  0.24 
Social Capital Hedosophia Holdings Corp. Iv  0.24 
Plum Acquisition Corp I  0.24 
Eq Health Acquisition Corp   0.24 
Horizon Acquisition Corporation Ii  0.24 
Lazard Growth Acquisition Corp I  0.23 
Queen s Gambit Growth Capital  0.23 
First Reserve Sustainable Growth Corp   0.23 
Spartan Acquisition Corp Iii  0.23 
Cf Acquisition Corp V  0.22 
Arctos Northstar Acquisition Corp   0.21 
Climaterock  0.20 
Oaktree Acquisition Corp. Ii  0.20 
Firstmark Horizon Acquisition Corp   0.20 
Qdm International Inc   0.20 
Tzp Strategies Acquisition Corp   0.20 
Crixus Bh3 Acquisition Company  0.19 
Apollo Strategic Growth Capital Ii  0.19 
Afternext Healthtech Acquisition Corp   0.19 
Jack Creek Investment Corp   0.19 
Tpg Pace Beneficial Ii Corp   0.19 
Ejf Acquisition Corp.  0.18 
Khosla Ventures Acquisition Co   0.18 
H.i.g. Acquisition Corp.  0.18 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com